BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Turaga RC, Satyanarayana G, Sharma M, Yang JJ, Wang S, Liu C, Li S, Yang H, Grossniklaus H, Farris AB, Gracia-Sancho J, Liu ZR. Targeting integrin αvβ3 by a rationally designed protein for chronic liver disease treatment. Commun Biol 2021;4:1087. [PMID: 34531529 DOI: 10.1038/s42003-021-02611-2] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Tang X, Li X, Li M, Zhong X, Fu W, Ao M, Xuan J. Enhanced US/CT/MR imaging of integrin αvβ3 for liver fibrosis staging in rat. Front Chem 2022;10:996116. [DOI: 10.3389/fchem.2022.996116] [Reference Citation Analysis]
2 Skorupan N, Palestino Dominguez M, Ricci SL, Alewine C. Clinical Strategies Targeting the Tumor Microenvironment of Pancreatic Ductal Adenocarcinoma. Cancers 2022;14:4209. [DOI: 10.3390/cancers14174209] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Abbas N, Yusuf M, Akhtar N, Khan RA. Contemporary nano-architectured drugs and leads for ανβ3 integrin-based chemotherapy: Rationale and retrospect. Nanotechnology Reviews 2022;11:204-19. [DOI: 10.1515/ntrev-2022-0020] [Reference Citation Analysis]